国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pseudomonas mendocina Glycine--tRNA ligase alpha subunit (glyQ) CSB-YP395834PZM
CSB-EP395834PZM
CSB-BP395834PZM
CSB-MP395834PZM
CSB-EP395834PZM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Pyrrolidone-carboxylate peptidase (pcp) CSB-YP395835YAL
CSB-EP395835YAL
CSB-BP395835YAL
CSB-MP395835YAL
CSB-EP395835YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Urease accessory protein UreD (ureD) CSB-YP395836YAL
CSB-EP395836YAL
CSB-BP395836YAL
CSB-MP395836YAL
CSB-EP395836YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) CSB-YP395837YAL
CSB-EP395837YAL
CSB-BP395837YAL
CSB-MP395837YAL
CSB-EP395837YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Ribosomal RNA large subunit methyltransferase M (rlmM) CSB-YP395838YAL
CSB-EP395838YAL
CSB-BP395838YAL
CSB-MP395838YAL
CSB-EP395838YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (kduI) CSB-YP395839YAL
CSB-EP395839YAL
CSB-BP395839YAL
CSB-MP395839YAL
CSB-EP395839YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Dihydroorotase (pyrC) CSB-YP395840YAL
CSB-EP395840YAL
CSB-BP395840YAL
CSB-MP395840YAL
CSB-EP395840YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Ribosomal RNA large subunit methyltransferase F (rlmF) CSB-YP395841YAL
CSB-EP395841YAL
CSB-BP395841YAL
CSB-MP395841YAL
CSB-EP395841YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis NADH-quinone oxidoreductase subunit N (nuoN), partial CSB-YP395842YAL
CSB-EP395842YAL
CSB-BP395842YAL
CSB-MP395842YAL
CSB-EP395842YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Probable manganese transport protein MntH (mntH), partial CSB-YP395843YAL
CSB-EP395843YAL
CSB-BP395843YAL
CSB-MP395843YAL
CSB-EP395843YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Succinyl-diaminopimelate desuccinylase (dapE) CSB-YP395844YAL
CSB-EP395844YAL
CSB-BP395844YAL
CSB-MP395844YAL
CSB-EP395844YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis DnaA-homolog protein hda (hda) CSB-YP395845YAL
CSB-EP395845YAL
CSB-BP395845YAL
CSB-MP395845YAL
CSB-EP395845YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Putative multidrug resistance protein MdtD (mdtD), partial CSB-YP395846YAL
CSB-EP395846YAL
CSB-BP395846YAL
CSB-MP395846YAL
CSB-EP395846YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Peptidase B (pepB) CSB-YP395847YAL
CSB-EP395847YAL
CSB-BP395847YAL
CSB-MP395847YAL
CSB-EP395847YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Dihydroorotate dehydrogenase (quinone) CSB-YP395848YAL
CSB-EP395848YAL
CSB-BP395848YAL
CSB-MP395848YAL
CSB-EP395848YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis UPF0434 protein YPDSF_2296 (YPDSF_2296) CSB-YP395849YAL
CSB-EP395849YAL
CSB-BP395849YAL
CSB-MP395849YAL
CSB-EP395849YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Deoxyribose-phosphate aldolase (deoC) CSB-YP395850YAL
CSB-EP395850YAL
CSB-BP395850YAL
CSB-MP395850YAL
CSB-EP395850YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP395851YAL
CSB-EP395851YAL
CSB-BP395851YAL
CSB-MP395851YAL
CSB-EP395851YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis SsrA-binding protein (smpB) CSB-YP395852YAL
CSB-EP395852YAL
CSB-BP395852YAL
CSB-MP395852YAL
CSB-EP395852YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pestis Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP395853YAL
CSB-EP395853YAL
CSB-BP395853YAL
CSB-MP395853YAL
CSB-EP395853YAL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>